Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Perspectives in treatment of AL amyloidosis.
Wechalekar AD, Hawkins PN, Gillmore JD. Wechalekar AD, et al. Br J Haematol. 2008 Feb;140(4):365-77. doi: 10.1111/j.1365-2141.2007.06936.x. Epub 2007 Dec 19. Br J Haematol. 2008. PMID: 18162121 Review.
Solid organ transplantation in AL amyloidosis.
Sattianayagam PT, Gibbs SD, Pinney JH, Wechalekar AD, Lachmann HJ, Whelan CJ, Gilbertson JA, Hawkins PN, Gillmore JD. Sattianayagam PT, et al. Among authors: wechalekar ad. Am J Transplant. 2010 Sep;10(9):2124-31. doi: 10.1111/j.1600-6143.2010.03227.x. Am J Transplant. 2010. PMID: 20883547 Free article.
ASCT for AL: all's well that ends well.
Wechalekar AD. Wechalekar AD. Blood. 2011 Oct 20;118(16):4298-9. doi: 10.1182/blood-2011-08-375105. Blood. 2011. PMID: 22021449 Free article. No abstract available.
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.
Venner CP, Lane T, Foard D, Rannigan L, Gibbs SD, Pinney JH, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD. Venner CP, et al. Among authors: wechalekar ad. Blood. 2012 May 10;119(19):4387-90. doi: 10.1182/blood-2011-10-388462. Epub 2012 Feb 13. Blood. 2012. PMID: 22331187 Free article.
191 results